A new study suggests developing new therapeutics that use cannabinoid receptors to treat chronic pain.
While endocannabinoids have been reported to play a role in anti-inflammation in some areas of the brain, a new study reveals they may cause inflammation in the cerebellum.
Receptor reacts to THC, as well as NAGly, a new study reports.
Cannabinoid receptors have been identified in the central nucleus of the amygdala, a key emotional hub in the brain.
Researchers have found a naturally occurring protein, know as diazepam binding inhibitor, secreted only in discrete areas of the brain may act as a Valium-like break in certain types of epilepsy.
The findings could provide new insights into brain diseases such as Alzheimer's, schizophrenia and depression.
Researchers report the protein FABP5, usually associated with diseases such as cancer and psoriasis, enhances cognitive function.
GABA accelerates the breakdown of endocannabinoids in the brain. Endocannabinoids are critical for emotional processing. The findings could lead to the development of new treatments for emotional behavioral disorders.
A new study finds THC reduces amyloid beta proteins in human neurons.
A rare genetic mutation has been associated with pain insensitivity. The findings could further research into new treatments to target pain.
When pregnant women consume diets high in polyunsaturated omega-6 fatty acids, an excess of endocannabinoids is produced which overloads the fetus, and impairs healthy brain development.
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems.
